Molecule Details
InChIKeyOQDPVLVUJFGPGQ-UHFFFAOYSA-N
Compound NamePiribedil
Canonical SMILESc1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)9
Pfam Stratification Homologous
Avg pChEMBL6.65
SourceBindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB12478
Drug NamePiribedil
CAS Number3605-01-4
Groups investigational
ATC Codes N04BC08
DescriptionPiribedil has been investigated in Parkinson's Disease.

Categories: Anti-Dyskinesia Agents Anti-Parkinson Agents (Dopamine Agonist) Anti-Parkinson Drugs Central Nervous System Agents Dopamine Agents Dopamine Agonists Nervous System Neurotransmitter Agents Nonergot-derivative Dopamine Receptor Agonists Piperazines
Cross-references: BindingDB: 85092 ChEBI: 92833 CHEMBL1371770 ChemSpider: 4684 PubChem:4850 PubChem:347828716 RxCUI: 8353 Wikipedia: Piribedil ZINC: ZINC000019537374
Target Activities (9)
Target Gene Organism Category Pfam pChEMBL Type Source
P18825 ADRA2C Homo sapiens Human PF00001 7.2 Ki BindingDB
P08913 ADRA2A Homo sapiens Human PF00001 7.0 Ki BindingDB
P14416 DRD2 Homo sapiens Human PF00001 6.9 Ki BindingDB
P25100 ADRA1D Homo sapiens Human PF00001 6.7 Ki BindingDB
P35462 DRD3 Homo sapiens Human PF00001 6.6 Ki BindingDB
P18089 ADRA2B Homo sapiens Human PF00001 6.5 Ki BindingDB
P21917 DRD4 Homo sapiens Human PF00001 6.5 Ki BindingDB
P08908 HTR1A Homo sapiens Human PF00001 6.3 Ki BindingDB
P35348 ADRA1A Homo sapiens Human PF00001 6.1 Ki BindingDB
DrugBank Target Actions (6)
Target Gene Target Name Action Type
P08908 HTR1A 5-hydroxytryptamine receptor 1A agonist targets
P14416 DRD2 D(2) dopamine receptor agonist targets
P35462 DRD3 D(3) dopamine receptor agonist targets
P18825 ADRA2C Alpha-2C adrenergic receptor antagonist targets
P21917 DRD4 D(4) dopamine receptor antagonist targets
P41595 HTR2B 5-hydroxytryptamine receptor 2B antagonist targets